Author: Sonorous Neurovascular

HCM & HRIS

Sonorous Neurovascular Receives FDA IDE Approval for First U.S. Pivotal Trial of a Venous Sinus Stent to Treat Pulsatile Tinnitus

October 10, 2026
Sonorous Neurovascular
No Comments

B-SILENT 2 adds a U.S. pivotal study to the company’s international clinical program and advances its…